We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byDomenica Guglielmi
Modified over 5 years ago
Total Lymphadenectomy and Nodes-Based Prognostic Factors in Surgical Intervention for Esophageal Adenocarcinoma Alberto Ruffato, MD, PhD, Marialuisa Lugaresi, MD, PhD, Benedetta Mattioli, MD, PhD, Massimo Pierluigi Di Simone, MD, Agnese Peloni, MD, Niccolò Daddi, MD, PhD, Angela Montanari, MS, Laura Anderlucci, MS, PhD, Sandro Mattioli, MD The Annals of Thoracic Surgery Volume 101, Issue 5, Pages (May 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Cumulative cancer-specific survival grouped by (A) tumor pathologic stage and (B) tumor pathologic substage. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Conditional inference tree with 2 terminal nodes. The best split (p = ) in lymph node ratio (LNR) (predictor variable) to maximize separation of survival functions (based on log-rank test) was detected with LNR = 0.04 (p = ). In y-axis, proportion surviving and in x-axis, the months after operation are displayed. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Esophagogastric Metaplasia Relates to Nodal Metastases in Adenocarcinoma of Esophagus and Cardia Alberto Ruffato, MD, PhD, Sandro Mattioli, MD, Ottorino.
Elizabeth A. David, MD, David T
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Endoscopic Ultrasound for Early Stage Esophageal Adenocarcinoma: Implications for Staging and Survival Traves D. Crabtree, MD, Wael N. Yacoub, MD, Varun.
Association of Perioperative Fluid Balance and Adverse Surgical Outcomes in Esophageal Cancer and Esophagogastric Junction Cancer Shenhai Wei, MD, PhD,
Joshua E. Rosen, BASc, Hari B
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,
Castigliano M. Bhamidipati, DO, MS, George J
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,
© 2023 SlidePlayer.com Inc. All rights reserved.